# CRH public limited company (CRH) · Edgar & Edgarette company card

> CRH public limited company (CRH) grew revenue 5.3% in FY2025 to $37.4 billion, operating margin 14.5%, equity 41.2% of assets, and dividend per share up 4 years running. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 849395 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/CRH) · [JSON](https://www.pops4.com/boards/company/CRH.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $37.4B |
| Revenue growth, 1 year | 5.3% |
| Revenue growth per year | 6.4% |
| Operating margin | 14.5% (prior year 13.8%) |
| Net margin | 10.1% |
| Operating cash flow | $5.6B |
| Capital spending | $2.7B |
| Free cash flow | $2.9B |
| Cash | $4.1B |
| Long-term debt | $17.5B |
| Total assets | $58.3B |
| Total equity | $24.0B |
| Equity ÷ assets | 41.2% |
| Return on equity | 15.8% |
| Dividend per share | $1.48 |
| Dividend years rising | 4 |

## Readings, computed from those figures

- Altman Z: 3.56 (safe zone)
- Piotroski F: 6 of 9 (solid)
- Health Harbor boat: New ship · no warning signs
- Cash Compass: In between · no clear cash pattern yet

## Edgarette's reading

Exposure: revenue $37.4B (FY2025), total debt $17.5B. Experience: revenue up 5.3% on the year, up 6.4% a year over 4 years; operating margin 14.5%, up from 13.8%. Soundness: equity 41.2% of assets, return on equity 15.8%, dividend per share up 4 years running. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $35.3B and $41.0B next year (method v4.1: its own 4-year record of growth weighed at 50% against $10B+ filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $33.0B to $43.5B. A statistical range, not company guidance. Against peers (9 filers, $50M+ revenue, its industry group): growth 5.3% against 3.2%.

Range logged 2026-10-30, receipt ba7fd44a14e74467, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 3, latest 2026-06-16 ([filing](https://www.sec.gov/Archives/edgar/data/849395/000162828026043417/0001628280-26-043417-index.htm))

## Recent filings

- 8-K · filed 2026-11-04 · 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/849395/000119312526446496/0001193125-26-446496-index.htm)
- 10-Q · filed 2026-10-29 · [filing](https://www.sec.gov/Archives/edgar/data/849395/000084939526000013/0000849395-26-000013-index.htm)
- 8-K · filed 2026-10-29 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/849395/000084939526000012/0000849395-26-000012-index.htm)
- 8-K · filed 2026-10-23 · 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/849395/000119312526429523/0001193125-26-429523-index.htm)
- 10-Q · filed 2026-07-30 · [filing](https://www.sec.gov/Archives/edgar/data/849395/000162828026050755/0001628280-26-050755-index.htm)
- 8-K · filed 2026-07-30 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/849395/000162828026050752/0001628280-26-050752-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0000849395.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=849395

## Cite

POPS4, Edgar & Edgarette: CRH public limited company (CRH) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/CRH. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.